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Development and validation of a
questionnaire assessing the quality of life
impact of Colour Blindness (CBQoL)
John A. Barry1,3* , Susan Mollan2, Michael A. Burdon2, Michelle Jenkins3 and Alastair K. Denniston2,4
Abstract
Background: Congenital colour vision deficiency (CVD), commonly called ‘colour blindness’, affects around 8% of men
and 0.4% of women. Although many aspects of health (e.g. change in colour of urine) and healthcare (e.g. coloured
medication, colour-coded diagnostic tests), and modern life depend upon colour coding (e.g. graphs, maps, signals),
the impact of colour blindness on everyday life is not generally considered a topic of importance. This study is the first
to create and validate a questionnaire measuring the quality of life (QoL) impact of being colour blind.
Methods: This study consisted of two phases. Firstly, the questionnaire design and development phase was led by an
expert panel and piloted on a focus group. Secondly, an online sample of 128 men and 291 women filled in
the questionnaire, and the psychometric properties of the questionnaire were analysed using principal components
analysis (PCA). The scores of colour blind (CB) participants and normal-sighted controls, controlling for age and sex,
were compared using matched t-tests.
Results: The PCA resulted in a questionnaire with three domains (or subscales): QoL for Health & Lifestyle, QoL for Work,
and QoL for Emotions. Controlling for age, there was a significantly greater negative impact on QoL for CB people than
normal-sighted controls in regards to confusion over colour in various aspects of their health (p = 5 × 10−7), work (p = 1.
3 × 10−7), and emotional life (p = 6 × 10−5).
Conclusion: Colour blindness can significantly impact quality of life for health, emotions, and especially careers. The tool
developed here could be useful in future clinical studies to measure changes in CBQoL in response to therapy in
conditions where colour vision is affected. We also discuss ways in which everyday problems related to colour vision
might be reduced, for example, workplaces could avoid colour coding where a non-colour alternative is possible.
Keywords: Colour vision deficiency, Colour blind, Quality of life, Psychology, Questionnaire, Factor analysis, Principal
components analysis
Background
Colour blindness (CB) (also known as colour vision defi-
ciency, CVD) is a common condition, with around 8% of
men and 0.4% of women being affected from birth (i.e.
congenital CB) [1]. Many aspects of modern life
increasingly require accurate colour vision [2], from
colour-coded maps and graphs, to electronic wiring &
components, to signalling & communications, and even to
reading text set in a coloured background. Despite the
prevalence of this condition, and the many restrictions
that being colour blind puts on various aspects of life,
there has been surprisingly little research on the quality of
life (QoL) impact of congenital colour blindness.
In their review of literature on the impact of colour
blindness on everyday functioning, Chan et al. describe
effects across the lifespan [3]. In ‘play age’, children will
experience learning difficulties (e.g. coloured chalk on a
blackboard), impaired social play (e.g. colours of team
clothes in sports). Children may also experience behav-
ioural issues (e.g. embarrasment and social withdrawl, or
being a fussy eater due to unappetising appearance of
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colour of foods such as vegetables). Colour blind school-
children may fall behind in subjects where colours are a
necessary part of learning, and colour blindness may be
treated as “something of a joke” (Sullivan 2011, p.21) [4].
The problems experienced in younger life may continue
into adulthood, especially for those who have not received
a diagnosis. Career choices for young adults may be re-
stricted, for example, the armed forces rely on colours for
signaling, and colour is important in the sciences [5, 6].
Such problems extend into middle and late adulthood,
with restrictions at work, problems with driving safely,
and problems taking coloured medication correctly [2].
Tagarelli et al. found that 66–90% of colour blind people
have problems with everyday tasks, such as reading charts
or knowing when meat is cooked properly [7].
Although validated questionnaires exist that measure
QoL aspects of visual functioning, these are designed to
measure the general impact of ocular pathology rather
than colour vision problems. Moreover, they are very
limited in their ability to assess the impact of colour vi-
sion deficiency on QoL, for example, the popular VFQ-
25 - and even the larger NEI-VFQ - contain only one
item (choosing / matching clothing) to measure colour
vision problems [8].
The aim of this study was to develop and validate a QoL
measure of colour blindness, and determine whether
colour blindness has a significant impact on quality of life
compared to people with normal colour vision.
Method
Design
This study was an online survey analysed using standard
questionnaire validation methods, such as principal
components analysis. People with CB were involved in
the design and implementation of this study.
This first part of this paper describes the development
of the questionnaire, and the second part describes the
validation of the questionnaire. In the second part, the
scores of people with CB are compared with the scores
of people with normal colour vision.
Setting
The setting of this study was online.
Participants
Participants were recruited from various sources, mostly
online (details in the section Initial Validation of Final
CB Questionnaire, below). They were categorised as
being CB or not, as described in the Materials section
below. The authors use the common term ‘colour blind-
ness’ (CB) for the sake of clarity, but recognize that
participants in fact had varying degrees of colour vision
deficiency (CVD). Characteristics of the sample are
shown in Table 1 below.
Ethical approval was granted by the University College
London Research Ethics Committee (Project ID: 4075/
004). Informed consent was given by the participants
before filling in the questionnaire.
Phase 1: development of CB questionnaires
Items for the questionnaire were developed through (a)
a literature search, (b) an online lay focus group consist-
ing of six individuals with CB and two normally-sighted
people, recruited via Psychology on The Net and snow-
ball sampling, and (c) an expert focus group consisting
of three consultant ophthalmologists (SM, MAB, AKD),
and a psychologist (JB) who has published several papers
on questionnaire development in health and psycho-
logical conditions. JB has congenital deuteranopia (‘red-
green’ CB). At these meetings, discussion focused on the
types of experiences that were important to people with
CB. Three main themes emerged: the career impact of
being CB, the emotions associated with being CB, and
the lifestyle impact of being CB. These various experi-
ences were listed and then phrased as questions, with
appropriate Likert scales added. Through this process,
the 36 items that formed the basis of the questionnaire
were derived.
Six-point Likert scales were used, with lower scores in-
dicating worse QoL. Responses were on a 6-point Likert
scale from 1 = A severe problem, to 6 = No problem,
with an option for ‘not applicable’. In this development
Table 1 Description of the colour vision and social background of the participants by sex (128 men and 291 women)
Colour vision category χ2
CB (N = 65) Borderline (N = 22) Normal vision (N = 332)
Sex Male 57 (88%) 6 (27%) 65 (20%) 118.984a
Female 8 (12%) 16 (73%) 267 (80%)
SEC Managerial 38 (65%) 10 (56%) 183 (68%) 4.328b
Intermediate 5 (9%) 0 (0%) 24 (9%)
Manual 15 (26%) 8 (44%) 63 (23%)
CB colour blind (Ishihara score 0–9), Borderline normal vision (Ishihara score 10–12), Normal vision (Ishihara score 13–15). SEC Socioeconomic class. Note 17% (73
of 419) of SEC responses were missing or uncategorisable, thus totals do not add up to Ns for each group as a whole
a Sig value: p = 1.5 × 10−26
b Correction with Fisher’s exact test, as three cells had expected frequencies of less than 5
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phase, the questionnaire was administered to six CB
people and two normal vision (NV) controls. The survey
was completed online. All suggestions for revisions to
the survey were recorded and changes to the question-
naires were made based on these suggestions. For ex-
ample, an item was added regarding judging by colour
whether food is sufficiently cooked. Also, the back-
ground colour of the survey was changed so that the
questionnaire was easier for CB people to use.
A principal components analysis (PCA) was conducted
to examine the factor structure of the questionnaire. The
PCA used Varimax rotation and Kaiser normalization.
Missing data were deleted pairwise, so that where a partici-
pant gave some answers but had not completed the ques-
tionnaire, the responses they gave could be included in the
analysis. Extraction and retention of factors was based on
visual examination of the scree plot [9] and eigenvalues of
>1.0 were retained [10]. The threshold for the Kaiser-
Meyer-Olkin (KMO) Measure of Sampling Adequacy was
0.6 [11]. Cronbach’s α coefficient values were assessed [12]
in order to measure the internal reliability of a question-
naire. The usual threshold for acceptability for Cronbach’s
α is 0.7 [13]. A factor loading threshold of .60 was applied
to enhance the strength of factors, so only items of this
strength, or with loadings that could be rounded up to .60,
were retained. For factor loadings of .6 to be significant, a
minimum of 85 participants are required to allow sufficient
statistical power [14].
Phase 2: initial validation
Initial validation of final CB questionnaire For the
initial validation of the questionnaire, an online survey
invited individuals with CB and NV controls to fill in the
questionnaire. Participants were recruited between Sept
2014 and Sept 2015 from relevant websites and social
media sources, including Colour Blind Awareness, the
Men’s Health Forum, Psychology on The Net, Online
Psychology Research and Birmingham University’s Medical
School Newssheet.
Materials
Ishihara colour test
Colour blindness was assessed using the Ishihara Colour
Test [15]. This is a set of up to 24 coloured plates [16]
in which the visibility of numbers or letters will depend
upon the colour vision of the viewer. The plates are
scored by giving one point for each plate correctly iden-
tified. This study used 15 plates, the number required to
identify colour deficiency. Those who scored up to 9
plates correctly were categorized as colour blind; those
scoring 13 or more were considered to have normal
colour vision. For the purposes of our study, those who
scored between 10 and 12 were categorized as border-
line colour blind.
Health-related Quality of Life (HRQoL)
To assess the degree to which CB might have an impact
on health-related quality of life, the participants filled in
the Short Form 36 (SF-36) [17]. This 36-item health
questionnaire is widely used and assesses QoL for eight
dimensions of health. The subscales are rated on Likert
scales, with lower scores indicating worse health. The
response format of the scales varies, for example, ‘excel-
lent’ to ‘poor’ for one item, and ‘not at all’ to ‘all the
time’ for another. For the purpose of the present study,
only the mental health (SF-36 MH) subscale was used.
The Cronbach’s alpha for this subscale is 0.926.
Positive state of mind
To assess the degree to which CB might impact mental
health, The Positive Mindset Index (PMI) [18] was admin-
istered to participants. This scale consists of six items
(happiness, confidence, being in control, emotional stabil-
ity, motivation and optimism) on a 5-point Likert scale.
This scale shows good internal reliability (Cronbach’s
alpha = 0.926) and shows good concurrent validity with
measures of mental health [18, 19].
Characteristics of the sample
Table 1 shows the characteristics of the sample.
As expected, there were significantly more men than
women with colour blindness (χ2 = 118.98, df = 2,
p = 1.5 × 10−26). Of the 65 CB participants, four (6%)
reported that their CB was acquired rather than congenital.
There was no significant difference in the socioeconomic
background distributions in the three vision groups, with
56–68% coming from a professional background, 23–44%
from a manual background, and 0–9% from an intermedi-
ate background.
The mean (SD) age of the CB group (44.8 ± 15.6 years)
was significantly older than that of the NV group
(30.1 ± 15.1 years) (p = 9 × 10−11). In order to reduce
any effect of age on outcomes, matching of participants
in each group by age was carried out.
Of the 56 CB participants aged 18 to 65 years old, it
was possible to match 30 of them by age to the nearest
year to one or more NV community controls. This age
limit of 65 years was chosen both because it spans the
average working age in the UK and avoids the general
declining of vision which is common with older age.
Where there was more than one person in a group of
the same age, the mean of their scores was used. For ex-
ample, for participants aged 30 years old, there was one
CB and three NV controls, thus the sole CB score was
compared to the mean of the three NV scores. In some
cases there was more than one CB participant of the
same age e.g. at age 45 the mean of four CB participants
was paired with the mean of six controls. Using this
process, 30 age-matched pairs were possible from 46 CB
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and 199 control participants. Because men and women
typically have different rates and types of colour blind-
ness, the groups were further subdivided by sex. Fewer
age-matched pairings were possible within each sex: 11
pairings of men (16 CB and 18 controls) and five pair-
ings of women (five CB and 20 controls).
Initial validation analysis
As a first step in validating a newly developed question-
naire, the construct validity of the questionnaire can be
tested by assessing differences in scores between groups
who are known to be different in relevant ways. In the
present study, the two groups were the CB and normal
sighted controls, matched for age. The mean scores on
the Ishihara test, CBQoL, PMI and SF-36 MH were
compared using matched t-tests. In the QoL question-
naire subscales, a higher score indicated a better QoL.
All statistical analyses were carried out using SPSS stat-
istical software for Windows, Version 22 (Armonk, NY:
IBM Corp). The significance threshold was set at .05,
and all P values were 2-tailed.
A further step in validating new questionnaires is test-
ing how much they are in agreement with existing vali-
dated questionnaires measuring similar constructs. This
is known as concurrent validity, and acceptable concur-
rent validity is indicated by a Pearson’s correlation coef-
ficient (r) of 0.5 or more [20]. The criterion by which
the new questionnaire subscales were measured was the
Ishihara Colour Blindness Test [15], which assesses
colour vision acuity. Thus concurrent validity between
the CBQoL questionnaire and the Ishihara was assessed
in this way.
To assess concurrent validity with health and psycho-
logical aspects of QoL, two other questionnaires were
used. Firstly, the QoL mental health subscale of the SF-
36 [17], on which lower scores indicate worse mental
health. Secondly, the Positive Mindset Index (PMI) [18]
was used, on which higher scores represent a more posi-
tive state of mind.
Results
Development of final CBQoL questionnaire
The mean (SD) time taken to complete the survey was
15.26 (±10.28) minutes. The CBQoL consisted of 36
items, identified as being issues relevant to being colour
blind. The stimulus question was: “Some people have
had difficulties related to colours in their everyday life,
regardless of whether they have a diagnosis of colour
blindness or not. Please answer the following questions,
which are about how much seeing colours may have been
a problem for you. Please answer the questions whether
you have a diagnosis of colour blindness or not. For each
of the questions below, please state how much any of the
following situations have ever been a problem for you
because of difficulty in seeing colours properly”.
Responses were on a 6-point Likert scale from 1 = A
severe problem, to 6 = No problem, with an option for
‘not applicable’. The scores on the subscales (Table 2)
were converted to means (Table 3) with a maximum
score of 6 and minimum of 1. The 36 items relating to
problems caused by colour confusion were: career limi-
tations, avoiding aspects of work, underachievement,
problems with coloured charts, coloured text, buying
clothes, driving, reading maps, avoiding discussions
involving colours, caused problems in family, social
activities, socializing, ripeness of fruit, food cooked fully,
choosing groceries, coloured medication, sunburn, mole
on skin, urine, blood in faeces, avoiding activities, felt let
others down, embarrassment, depression, anxiety, un-
confident, feeling different, self-esteem, annoyed, wor-
ried, problems with sports, problems in dim lighting,
pain, concentration, confusion, and lethargy. For the
purposes of this initial research into CVD, there were
also free text questions to allow participants to state
other emotional and physical symptoms not in the list;
the free text responses did not add a great deal to the
statistical information and are not discussed below, and
are not part of the CBQoL.
Factor structure of the CBQoL
After incomplete responses were eliminated, there were
91 (N = 69 CB and N = 22 borderline normal) participants
in this analysis, including four participants who did not
state their gender. This number exceeds the minimum of
85 participants required for factor analysis [14].
The principal components estimation resolved in nine
iterations. The scree plot indicated that five factors were
found. Together, these factors accounted for 76.58% of
the variance in scoring after extraction. Two factors con-
tributed less than 10% so were eliminated from further
analysis in order to reduce the influence of relatively
weak items. The remaining three factors accounted for
62.11% of the variance in scoring. The observed KMO of
0.911 indicated sound underlying factors. Bartlett’s Test
of Sphericity was significant (χ2 = 2527.577; df = 630;
p = 1 × 10−223), indicating good factorability of the cor-
relation matrix.
The above analyses resulted in the final version of the
CBQoL questionnaire consisting of three subscales and 23
items (Table 2). The factor loadings are shown in Table 2.
Cronbach’s α reliability for all 23 items was .979.
Initial validation of the CBQoL
Table 3 shows that the CB participants scored signifi-
cantly lower on the Ishihara and the three CBQoL sub-
scales, but not significantly lower on the mental health
subscale of the SF-36 HRQoL or PMI.
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For the CB participants, there was a positive correlation
between the Ishihara test and the CBQoL subscales:
Health & Lifestyle: r = .533, n = 91, p = 5 × 10−8; Work:
r = .599, n = 91, p = 5 × 10−8; Emotions: r = .315, n = 91,
p = 0.002. This shows acceptable concurrent validity of
the CBQoL for the Health & Lifestyle and Work subscales,
though weaker evidence for the concurrent validity of the
Emotions subscale. In contrast, the correlations between
the Ishihara test and QoL subscales in the control group
were weak (average r = .106).
In a further validation of the Health & Lifestyle and
Emotions subscales, for the CB group only there was a
Table 3 Mean (SD) scores for the male and female age-matched participants separately.
Age- and Gender-Matched Age- and Gender-Matched Age-Matched
Male Female All participants
(N = 11 pairings) (N = 5 pairings) (N = 30 pairings)
CB Normal t p value CB Normal t p value CB Normal t p value
Ishihara 3.0 (1.3) 14.5 (0.7) −32.2 1.9 × 10−10 4.2 (2.7) 14.9 (0.2) −9.1 .001 3.4 (2.0) 14.6 (0.5) −29.6 2.5 × 10−23
CBQoL Emotion 4.1 (1.9) 5.7 (0.5) −2.8 .018 4.7 (1.6) 6.0 (0.0) −1.9 (ns) 4.4 (1.5) 5.9 (0.2) −5.5 6 × 10−5
CBQoL Health 3.8 (1.6) 5.7 (0.6) −4.2 .002 4.1 (2.1) 6.0 (0.1) −1.8 (ns) 4.1 (1.4) 5.8 (0.2) −6.4 5 × 10−7
CBQoL Work 3.8 (1.8) 5.6 (0.7) −4.5 .001 4.5 (1.6) 6.0 (0.2) −1.9 (ns) 3.6 (1.6) 5.9 (0.2) −7.8 1.3 × 10−7
Positive Mindset 3.8 (0.8) 3.8 (0.5) 0.2 (ns) 3.0 (0.8) 3.6 (0.2) −1.8 (ns) 3.5 (0.7) 3.7 (0.3) −1.4 (ns)
SF-36 MH 3.9 (0.4) 3.9 (0.5) 0.2 (ns) 3.2 (0.8) 3.7 (0.4) −1.2 (ns) 3.5 (0.7) 3.7 (0.4) −1.1 (ns)
CBQ-oL Colour Blindness Quality of Life scale, SF-36 MH mental health subscale of the MOS 36-Item Short Form Health Survey, PMI Positive Mindset Index
Comparisons between CB participants and NV controls are made using matched t-tests. For men there were 11 age-matched pairings from 16 CB participants and
18 NV controls, and for women there were 5 age-matched pairings from 5 CB participants and 20 NV controls. Comparisons between CB and NCV are made using
matched t-tests. The 30 age-matched pairings were from 46 CB and 199 control participants
Table 2 Principal components analysis of CBQoL items
Component
Items Health & Lifestyle Emotions Work
Not noticing change in colour of skin due to sunburn .810
Difficulty choosing groceries due to colour .766
Not noticing change in colour of mole on skin .763
Can’t tell when food is cooked due to colour .755
Difficulty choosing or buying clothes .749
Being confused about colour of pills or other medication due to colour-coding .733
Not noticing blood in stools (faeces) .718
Difficulty knowing when fruit is ripe due to colour .711
Difficulty reading maps (e.g. London Underground map) .707
Not noticing a change in colour of urine .679
Problems playing sports (e.g. colours of team clothing, colours of snooker balls etc) .630
Feeling anxious because of issues caused by problems seeing colours .880
Feeling depressed because of issues caused by problems seeing colours .846
Feeling unconfident because of issues caused by problems seeing colours .820
Feeling embarrassed or humiliated because of CB issues .816
Feeling low self esteem because of issues caused by problems seeing colours .778
Feeling anxious because you might not realise when you can’t see a colour properly .767
Feeling different to other people because of issues caused by problems seeing colours .720
Felt that had let down self or others due to problems seeing colours .692
Avoiding conversations where colours are discussed .627
Being limited in choice of work or career .754
Difficulty performing work or other activities (e.g. charts) .658
Accomplishing less than would like at work or in career .621
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statistically significant, moderate positive correlation
between the CBQoL Health & Lifestyle subscale and the
mental health subscale of the SF-36 (r = .297, n = 63,
p = 0.018), and there was a statistically significant, moder-
ate positive correlation between the CBQoL Emotions
subscale and the PMI (r = .393, n = 63, p = 0.001).
Although these correlations are weaker than ideal for con-
current validity, they are stronger than those for the con-
trol group (CBQoL Health & Lifestyle subscale and the
SF-36: r = .200, n = 322, p = 0.0003; CBQoL Emotions
subscale and the PMI; r = .057, n = 321, p = 0.308), which
supports ‘known groups’ validity.
Discussion
In this study we describe the development of a question-
naire measure of the QoL impact of being colour blind.
The presence of CB was based on self-report, with con-
firmation by Ishihara testing. Both male and female CB
participants scored significantly lower on the three
CBQoL subscales than NV participants.
CB participants scored significantly lower on the Emo-
tion CBQoL subscales than NV participants. This echoes
the finding by Sullivan [4] that colour blind children
may feel embarrassed about not knowing colours. The
present study expands on the range of issues that may
be seen in CB adults, including feeling anxious, de-
pressed and lacking in self-esteem due to issues caused
by being CB. CB participants did not score significantly
differently to NV on the mental health subscale of the
SF-36 HRQoL, nor on the PMI, though Table 3 shows
that colour blind women had slightly more difficulty
with SF-36 MH and PMI than their NV counterparts.
CB participants scored significantly lower on the CBQoL
Health & Lifestyle subscale than NV participants. This echoes
findings of Spalding [1] regarding problems seeing blood in
stools, and [21] because we found that worse colour vision
was correlated with the item (in Table 2) assessing confidence
about taking coloured medication (rs = .317, p = 3 × 10
−7).
CB participants scored significantly lower on the
CBQoL Work subscale than NV participants. This sup-
ports previous research finding that CB creates a barrier
to entry to a range of occupations, and besides those oc-
cupations, problems are experienced with colours within
many jobs that do not so obviously rely on colour [3].
These findings demonstrate that the negative effect of
colour blindness on QoL can be profound. For example,
a Cohen’s d of 0.8 or more is considered a large effect
size, and the effect size of colour blindness on the Work
subdomain of CBQoL is a Cohen’s d of 1.83 (the mean
and SD data is in Table 3).
Strengths of the study
In addition to its primary aim of developing the first
QoL measure specific to CB, the present study provides
a quantitative estimate of the impact of this common
but often overlooked condition. This study is the first to
assess the QoL impact of problems with colour vision in
people with colour blindness compared to normally
sighted controls. The three subscales show good psycho-
metric properties in terms of factor loadings, Cronbach’s
alpha and other relevant measures.
The CBQoL has further potentially useful applications
e.g. in contrasting the effects of congenital vs acquired
colour blindness, the effects of different types of con-
genital colour blindness (e.g. across protan, deutan,
tritan axes) and the varying impact of different acquired
diseases (e.g. retinal pathologies vs optic neuropathies).
A future study of an intervention for people with
acquired colour vision problems might use the CBQoL
to measure changes in QoL from pre- to post-treatment.
Limitations of the study
The cause of CB was not explored in this study. It may
be that some forms of CB have a much less - or much
greater - impact on QoL than we observed here. Future
work will explore the variation in impact between con-
genital and acquired forms of CB.
The method of recruitment to this study may have led to
sample bias. Most participants were recruited online, which
limits the sample to those who had access to the internet
and/or involved in colour blindness forums, or recruited
through professional groups. This presumably contributed
to a relatively high proportion of participants in each group
being from a professional background, though this was not
significantly different across the CB and NV groups. It is
worth noting however that CB people may have career lim-
itations and different employment due to colour difficulties
than NV people [7]; inadvertent sampling bias towards
professional groups may therefore exclude people whose
careers have been most negatively affected by CB and
therefore underestimate the impact of CB on work related
QoL. Future research using the CBQoL might benefit from
recruiting from non-online sources (e.g. in clinics) and
recruiting more working class participants.
It is noted that the Ishihara test was not administered
face-to-face by the research team but was administered
online in uncontrolled conditions i.e. in participants’
own homes, where backlighting and monitor settings
were not standardised by the experimenters; we cannot
therefore externally validate the accuracy of the Ishihara
scores. However the fact that the Ishihara scores were
strongly correlated with the Work and Health & Life-
style CBQoL subscales indicates some evidence of good
concurrent validity.
Conclusions
Colour blindness is a common condition, which can sig-
nificantly impact quality of life. Problems may occur in
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health, lifestyle, emotions, and especially careers. Although
congenital colour blindness occurs more frequently in
men, colour blindness arising from a range of acquired
conditions may affect both sexes. We suggest three things
that might help these problems: firstly, incorporating CB
screening into pre-school health checks; secondly, raising
awareness of CB in the general population, and thirdly,
where possible, workplaces should avoid colour coding
(e.g. charts) where a non-colour alternative is possible.
Practical approaches to the implementation of a CB-
supportive working environment can be found at http://
www.colourblindawareness.org/business/.
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